If you enjoy this content, please share it with a colleague
Brainlab
RELATED CONTENT
Brainlab announced first patient treatments on a fully integrated radiation oncology solution that combines its ExacTrac patient positioning with the Elekta Versa HD linear accelerator (LINAC). Working in synergy, these technologies determine positioning and treatment accuracy for cancer patients.
Voyant Health, a Brainlab company, announced that it has received U.S. Food and Drug Administration (FDA) clearance on TraumaCad Mobile, a mobile solution for pre-operative orthopedic surgical planning and digital templating.
Brainlab announced U.S. Food and Drug Administration (FDA) 510(k) clearance for two software modules for radiation oncologists and neurosurgeons — Adaptive Hybrid Surgery and Automatic Brain Metastases Planning — to round out the Brainlab portfolio.
Brainlab announced the installation of the 625th ExacTrac X-Ray. ExacTrac X-Ray provides sub-millimetric precison and a unique approach for solving the complexities associated with intra-fractional patient motion by internally verifying the patient’s position with stereoscopic X-ray at the time of treatment, even at non-coplanar couch positions. ExacTrac X-Ray monitoring is especially valuable for cranial stereotactic radiosurgery (SRS) and spinal stereotactic body radiation therapy (SBRT) treatments.
Olympus announced it has reached a deal with Munich-based Brainlab to be the exclusive U.S. distributor of Kick Navigation.
Arc-based radiation therapy continues to gain ground as physicians opt for treatment options that not only are more precisely tailored to each tumor site, but also delivered in fewer visits, which is significantly more convenient for both patients and cancer centers. With a variety of radiation therapy techniques available, from intensity-modulated radiation therapy (IMRT) and whole-body irradiation (WBI) to proton therapy and stereotactic body radiation therapy (SBRT), cancer centers around the country are now, more than ever, able to offer patients a more effective solution for targeting and treating their diseases.
July 24, 2014 — Brainlab announced the release of its Elements automatic brain metastases planning software. The new software will simplify stereotactic radiosurgery (SRS) planning for metastatic brain tumors and is the newest addition to the Elements A La Carte software portfolio. The software is a work in progress and currently not for sale in the United States.
Although the fundamental workflow has not changed for treatment planning systems over the years, as technology improves, new features are added to enhance workflow and function.
The radiation therapy market, hit hard in 2009 by the recession, saw a sharp decline in purchasing from which it has slowly recovered. During the last five years the market has been steadily growing, with capital equipment budgets for radiation oncology sites increasing. However, it has only been within the last year that equipment purchases for radiation therapy have leveled out. Purchasing decisions today are driven by two main factors: advancements in technology, including more targeted treatment, multifunctional capabilities and improved patient safety; and the evolving reimbursement model, which weighs patient outcomes and the quality of care delivered more heavily.
Barco, a visualization technology company, and Brainlab AG, Germany-based medical software technology manufacturer and marketer, announced their collaboration to provide medical content distribution and sharing.